Also trades as: COPN.SW (SIX) · $vol 3M

$63.10

-2.40 (-3.66%)

Weekly Expected Move ±7.0%

$54 $59 $63 $68 $72

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 43 · $1.1B mcap · 9M float · 0.0039% daily turnover · Short 76% of daily vol

Revenue

$105M -60.7% ▼

5Y CAGR: +11.5%

Gross Profit

$49M -80.2% ▼

5Y CAGR: -0.7%

Operating Income

-$10M -107.0% ▼

Net Income

-$4M -102.7% ▼

EPS (Diluted)

$-0.23 -102.8% ▼

EBITDA

$2M -98.6% ▼

5Y CAGR: -21.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$65M	$102M	$93M	$267M	$105M
YoY Growth	+6.8%	+56.9%	-9.1%	+187.5%	-60.7%
Cost of Revenue	$15M	$19M	$39M	$20M	$56M
Gross Profit	$50M	$83M	$53M	$247M	$49M
Gross Margin	76.7%	81.6%	57.6%	92.6%	46.5%
R&D Expenses	$11M	$16M	$19M	$373K	$32M
SG&A Expenses	$3M	$4M	$5M	$7M	$27M
Operating Expenses	$21M	$55M	$47M	$98M	$59M
Operating Income	$11M	$28M	$6M	$149M	-$10M
Operating Margin	17.1%	27.5%	6.6%	55.8%	-10.0%
Interest Expense	$9M	$9M	$9M	$126K	$182K
Income Before Tax	$24M	$24M	$2M	$153M	-$924K
Tax Expense	$2M	$7M	$6M	$20M	$3M
Net Income	$22M	$17M	-$5M	$133M	-$4M
Net Margin	33.3%	16.9%	-5.3%	49.9%	-3.5%
EPS (Diluted)	$1.28	$1.05	$-0.31	$8.12	$-0.23
EBITDA	$18M	$47M	$20M	$166M	$2M
Shares Outstanding	17M	16M	16M	16M	16M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$61M	$44M	$49M	$136M	$131M	$52M	$53M	$50M
Cost of Revenue	$23M	$19M	$20M	$23M	-$3M	$26M	$28M	$28M
Gross Profit	$37M	$25M	$29M	$113M	$134M	$26M	$24M	$22M
Gross Margin	61.6%	56.8%	58.3%	83.0%	102.5%	50.6%	46.5%	44.5%
R&D Expenses	$8M	$8M	$11M	$11M	-$10M	$18M	$16M	$15M
SG&A Expenses	$10M	$10M	$28M	$16M	-$9M	$14M	$13M	$17M
Operating Expenses	$19M	$18M	$29M	$26M	$72M	$28M	$29M	$32M
Operating Income	$20M	$7M	-$977K	$87M	$62M	-$1M	-$4M	-$9M
Operating Margin	32.9%	16.3%	-2.0%	63.8%	47.4%	-2.7%	-8.2%	-18.8%
Interest Expense	$9M	$9M	-$561K	$0	$53K	$0	$83K	$219K
Income Before Tax	$15M	$4M	-$2M	$89M	$65M	-$670K	-$248K	-$4M
Tax Expense	$6M	$2M	$4M	$13M	$7M	$1M	$1M	$936K
Net Income	$9M	$1M	-$6M	$76M	$57M	-$2M	-$2M	-$5M
Net Margin	15.4%	3.4%	-13.1%	55.8%	43.8%	-3.9%	-3.1%	-9.5%
EPS (Diluted)	$0.58	$0.09	$-0.40	$4.71	$3.43	$-0.13	$-0.10	$-0.28
EBITDA	$26M	$14M	$6M	$94M	$71M	$5M	$2M	-$3M
Shares Outstanding	16M	16M	16M	16M	16M	16M	16M	17M

CMOPF OTC